Sectors

The Telstra-sponsored venture firm has already begun investing through its third fund, which has now achieved a $350m final close.

Spinouts working on ketamine-based therapeutics, regenerative medicines for dogs and better sleep are among those that caught our eye this month.

The global food system is creaking — creating an impetus for global agriculture companies to invest in new solutions. Corporates took part in agtech deals worth a record $18bn last year. But are they investing fast enough?

Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.

David Clouse, a GCV Emerging Leader this year while at BP Ventures, will lead EIC Rose Rock, a $50m fund backed by Devon Energy, Onoek and Williams.

Senior investment director Karim Chehadé has announced his departure from Experian Ventures' strategic investment vehicle, three months after colleague Chan Yip Pang.

Alphabet led a $1bn round for its Verily subsidiary while Kimco Realty and The Silverman Group were part of Gotham Greens’ $310m series E.

Corporates have dramatically slowed down the rate at which they invest in startups, except in these two sectors.

Investment is building again in the sector after a lull, but big companies are hedging their bets on which type of aircraft will work best.

Hitachi grows its cell therapy portfolio, SoftBank slims down in India and Foresight Williams backs ID tags for diamonds.

Hanwha Group took part in a $250m round for Carrot General Insurance while JP Morgan Chase helped lift LetsGetChecked’s series D to $170m.